Sedation: definition and main pharmacological agents
Viel, E.; Eledjam, J.J.
Cahiers d'Anesthesiologie 43(2): 107-112
1995
ISSN/ISBN: 0007-9685 PMID: 7671069 Document Number: 445680
Document emailed within 1 workday
Related Documents
Hojo, M.; Nagasaka, Y.; Katayama, O.; Serizawa, I. 1981: Pharmacological study of Mequitazine (LM-209). (V). Pharmacological actions of a main metabolite of LM-209, mequitazine sulfoxide (LM-209 SO) Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 78(5): 431-438Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Wintrebert, F.; Certain, A. 1990: Evolution of the definition of AIDS. the main classifications of HIV infection Presse Medicale 19(41): 1892-1898
Longman, L.P.; Hibbert, S.; Davies, M.; Humphris, G. 2000: Sedation agents British Dental Journal 188(7): 354
Fuder, H. 1993: Is the use of short-acting anesthetics for long-term sedation meaningful? the pharmacological aspect Klinische Anasthesiologie und Intensivtherapie 44: 117-124
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Babaev, B.D.; Ostreikov, I.F.; Shtatnov, M.K.; Apostolidi, E.Y.; Nikitin, V.V.; Nadbitova, R.A. 2015: The use of Volatile Agents for Sedation in Children in the Intensive Care Unit Anesteziologiia i Reanimatologiia 60(3): 19-22
Fujita, S.; Ikezono, K.; Umezato, M.; Hosoki, E.; Toba, Y.; Ishikawa, M.; Kusunoki, A.; Shintani, S. 1992: General pharmacological properties of the main metabolite of flosequinan Arzneimittel-Forschung 42(10): 1212-1222
Bach, J.F.; Fournier, C. 1972: Definition and evaluation of immunosuppressive agents La Nouvelle Presse Medicale 1(35): 2289-2291
Cazzulani, P.; Pietra, C.; Abbiati, G.A.; Ceserani, R.; Oliva, D.; Civelli, M.; Tajana, A.; Nardi, D. 1988: Pharmacological activities of the main metabolite of flavoxate 3-methylflavone-8-carboxylic acid Arzneimittel-Forschung 38(3): 379-382
Lumholtz, I.B. 1980: Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 10th and last part. 4. other angina pectoris agents Sygeplejersken 80(20): 23
Roelofse, J. 2008: Sedation corner 25. The importance of the medical history questionnaire before conscious sedation. Sadj: Journal of the South African Dental Association 63(4): 253
Göksel, F.M.; Oztürk, E.O. 1973: The effects of certain pharmacological agents on the regulation of respiration Bulletin de Physio-Pathologie Respiratoire 9(3): 714-715
Chowdhury, A.R. 1987: Effect of pharmacological agents on male reproduction Advances in Contraceptive Delivery Systems: Cds 3(4): 347-352
Lumholtz, I.B. 1976: Drug information for nurses. Therapeutic main group: expectorants (mucous dissolving agents). 1 Sygeplejersken 76(44): 11
Higashino, K.; Moriwaki, Y. 1996: Pharmacological agents affecting uric acid metabolism Nihon Rinsho. Japanese Journal of Clinical Medicine 54(12): 3364-3368
Sizov, P.I. 1982: Barohysterography in study of the action of pharmacological agents on the myometrium Farmakologiia i Toksikologiia 45(2): 130-132
Davidoff, F. 1973: Oral hypoglycemic agents: the pharmacological basis of their clinical use Rhode Island Medical Journal 56(10): 409-414
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924